ENDRA Life Sciences Inc. Stock

$4.09

4.34% today

Nasdaq, Apr 02, 10:00 pm CET

ISIN

US29273B1044

Symbol

NDRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

ENDRA Life Sciences Inc. Stock price

$4.09

-22,350.41 99.98% 5Y

Nasdaq, Closing price Wed, Apr 02 2025

+0.17 4.34%

ISIN

US29273B1044

Symbol

NDRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$2.10m
Enterprise Value	$-550.00k
P/E (TTM) P/E ratio	0.00
EV/FCF (TTM) EV/FCF	0.07
P/B ratio (TTM) P/B ratio	0.82
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-18.14m
Free Cash Flow (TTM) Free Cash Flow	$-7.42m
Cash position	$3.23m
EPS (TTM) EPS	$-934.10
P/S forward	21.70
EV/Sales forward	negative
Short interest	7.57%

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Get Started for Free Today

ENDRA Life Sciences Inc. Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from ENDRA Life Sciences Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	- -	- 100%
- Direct Costs	0.21 0.21	25% 25% -
Gross Profit	-0.21 -0.21	25% 25% -
- Selling and Administrative Expenses	15 15	193% 193% -
- Research and Development Expense	3.19 3.19	36% 36% -
EBITDA	-18 -18	75% 75% -
- Depreciation and Amortization	0.21 0.21	25% 25% -
EBIT (Operating Income) EBIT	-18 -18	72% 72% -
Net Profit	-12 -12	14% 14% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

ENDRA Life Sciences Inc. Stock News

Neutral

Business Wire

●

2 days ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today announced a new strategic direction to develop and deploy its TAEUS system as a biomarker solution for the early detection and management of metabolic diseases in patients being treated with glucagon-like peptide-1 (GLP-1) drugs and other metabolic dysfunc...

Neutral

Business Wire

●

2 days ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and provided a business update. Business Update ENDRA made significant progress against many of the new initiatives discussed during the Company's August 22, 2024, con...

Neutral

Business Wire

●

4 months ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minimum bid price requirement set forth by The Nasdaq Stock Market LLC (“Nasdaq”). On November 21, 2024, the Company received notification from the Nasdaq Listing Qualifications Department confirming it...

More ENDRA Life Sciences Inc. News

Company Profile

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Head office	United States
CEO	Alexander Tokman
Employees	21
Founded	2007
Website	www.endrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now